RBJ, also known as RING finger and B-box domain-containing protein 1 (RBBP1), plays a crucial role in various cellular processes by acting as a multifunctional protein. It encompasses several functional domains, including a RING finger domain and a B-box domain, characteristic of E3 ubiquitin ligases involved in protein ubiquitination and degradation. RBJ is involved in chromatin remodeling, transcriptional regulation, DNA repair, and cell cycle progression. As a core component of the histone deacetylase (HDAC) complex, RBJ contributes to the recruitment of histone deacetylases to target genes, leading to chromatin condensation and transcriptional repression. Moreover, RBJ interacts with numerous other proteins, serving as a scaffold for the assembly of multiprotein complexes involved in various cellular processes.
Activation of RBJ involves several mechanisms that regulate its functions and interactions within the cell. One mechanism of activation is post-translational modifications, such as phosphorylation, acetylation, or ubiquitination, which can modulate RBJ's activity and stability. Phosphorylation of specific residues within RBJ can regulate its interaction with other proteins or alter its enzymatic activity, thereby affecting downstream cellular processes. Additionally, binding to specific ligands or cofactors can induce conformational changes in RBJ, facilitating its interaction with target proteins or promoting its recruitment to specific genomic loci. Furthermore, transcriptional regulation of RBJ expression levels can also impact its activation, as changes in its abundance can influence its availability for interaction with other proteins or its localization within the cell. Overall, the activation of RBJ is tightly regulated through various mechanisms to ensure proper cellular function and response to environmental cues.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Protein phosphatase inhibitor that can lead to increased phosphorylation within the MAPK pathway, a cascade that DNAJC27 regulates. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that indirectly activates Rho GTPase, thus potentially influencing DNAJC27's GTPase activity. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
CDK inhibitor that can lead to increased MAPK activity due to the absence of negative regulation, thus enhancing DNAJC27's regulatory role. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor, leads to the indirect activation of GTPase proteins, which DNAJC27 enables. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that indirectly affects the MAPK cascade by reducing competitive inhibition, thereby influencing DNAJC27. | ||||||
KN-62 | 127191-97-3 | sc-3560 | 1 mg | $136.00 | 20 | |
Inhibits CaMKII, thereby affecting intracellular protein transport that DNAJC27 is involved in. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Farnesyltransferase inhibitor, increasing GTPase activity by hindering negative regulation, affecting DNAJC27’s GTPase activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
PKC inhibitor that affects intracellular protein transport, a pathway that DNAJC27 is involved in. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Specific MEK inhibitor that activates ERK by preventing its dephosphorylation, affecting the MAPK cascade that DNAJC27 positively regulates. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, indirectly activates GTPase activity, affecting DNAJC27. | ||||||